We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is publishing an International Conference on Harmonisation (ICH) draft guideline that updates and explains specific preclinical steps drugmakers
should take to facilitate the conduct of product development and clinical trials for biotechnology-derived drugs.